Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea17ba87480b776cce77451f86b25bb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02cafa024a609da039578ce64fca655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffe7bfdea70fe1328990b7500ab975c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b42d38654d30b440cfe781c3bb1be6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32c48e5c92194ed91b10fa7204710e14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66ecc4a0dc908e1f4133f6dc4ea812d |
publicationDate |
2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2080516-A1 |
titleOfInvention |
Use of isothiocyanate derivatives as anti-myeloma agents |
abstract |
The invention concerns the use of glucomoringin and of its des-thio-glucoside having the following formulae:n nfor the preparation of a medicament for the treatment of myeloma. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015209395-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016162246-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147847-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026984-B2 |
priorityDate |
2008-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |